Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Gregory Lucier, Mark Dronsfield, Christoph Franz, Dietrich Stephan

Premium

Sanford-Burnham Medical Research Institute has elected Gregory Lucier to chairman of the board. He will take over from M. Wainwright Fishburn Jr., who will remain a member of the board.

Lucier is CEO and chairman of Life Technologies. He also served on Sanford-Burnham's Board of Trustees from 2005 until 2011. He holds a BS in engineering from Pennsylvania State University and an MBA from Harvard Business School.


Personalis has appointed Mark Dronsfield as director of European sales as part of the firm's recent formation of a UK subsidiary, Personalis UK Limited.

Dronsfield joins Personalis from RainDance Technologies, where he was most recently head of commercial operations in Europe. He has also held European commercial operations positions at Illumina, Affymetrix, and Life Technologies.


Roche has nominated Christoph Franz to chairman of the board of directors. He would succeed Franz Humer, who previously announced that he would not stand for re-election. Franz will not renew his contract as CEO of Lufthansa Group, which expires on May 31, 2014.


Dietrich Stephan has been named chair of the department of human genetics at the University of Pittsburgh Graduate School of Public Health and will also serve as the associate director of the Institute for Personalized Medicine, a collaborative initiative between the University of Pittsburgh Schools of the Health Sciences and UPMC.

Stephan was most recently founder, president, and CEO of Silicon Valley Biosystems. He holds a PHD in human genetics from the University of Pittsburgh.

The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.